ROBO1-specific BiCAR-NK cells

· Asclepius Technology Company Group (Suzhou) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ROBO1-specific BiCAR-NK cells, covering 2019-05-08 to 2019-05-08. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Research of ROBO1 Specific BiCAR-NK Cells on Patients With Pancreatic Cancer [Phase 1, Phase 2]